Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes

NCT05174507 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor- Investigator decision

Conditions

Postprandial Hypoglycemia

Interventions

DRUG: empagliflozin
DRUG: anakinra
OTHER: saline subcutaneous (s.c.) (placebo)
OTHER: tablet per oral (p.o.) (placebo)

Sponsor

University Hospital, Basel, Switzerland